logo

IBBQ

Invesco Nasdaq Biotechnology ETF·NASDAQ
--
--(--)
--
--(--)

Key Stats

Assets Under Management
72.89MUSD
Fund Flows (1Y)
21.48MUSD
Dividend Yield
0.88%
Discount/Premium to NAV
-0.01%
Shares Outstanding
2.51M
Expense Ratio
0.19%

About Invesco Nasdaq Biotechnology ETF

Issuer
Invesco Capital Management LLC
Brand
Invesco
Inception Date
Jun 11, 2021
Structure
Open-Ended Fund
Index Tracked
NASDAQ Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
IBBQ provides exposure to US biotech and pharma companies that are exclusively listed on the NASDAQ Stock Market. The index includes companies classified under the biotechnology or pharmaceuticals sub sector of the Industry Classification Benchmark. Companies from any capitalization may be included, but since weighting is based on market cap, it produces a basket that heavily favors large-caps and concentrates exposure in the top names. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. IBBQ may miss opportunities in companies traded on the NYSE, which several of the other similar funds are eligible to hold. The index is rebalanced quarterly and reconstituted annually in December.

Classification

Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharma, Biotech & Life Sciences
Strategy
Exchange-specific
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
NASDAQ-listed

Analysis

Sector

Healthcare

100.00%

Asset

Holdings

Symbol

Ratio

logo

GILD

Gilead Sciences
9.14%
logo

VRTX

Vertex Pharmaceuticals
9.08%
logo

AMGN

Amgen
8.16%
logo

REGN

Regeneron
5.88%
logo

ALNY

Alnylam Pharmaceuticals
3.50%
logo

INSM

Insmed
2.52%

Symbol

Ratio

logo

BIIB

Biogen
1.94%
logo

ARGX

argenx
1.87%
logo

ILMN

Illumina
1.73%
logo

UTHR

United Therapeutics
1.52%

Top 10 Weight 45.34%

10 Total Holdings

See all holdings

Related Funds

Seasonals

Volume Profile

Trade Flow Insight

Community Forum

Loading...

Related News

No articles available

You can ask Aime

No Data